Semaglutide has also been proven as an effective treatment for patients with obesity-related heart failure, improving symptoms, physical limitations, and exercise capacity even in those without diabetes [74, 75]
Effects of liraglutide compared with placebo on events of acute gallbladder or biliary disease in patients with type 2 diabetes at high risk for cardiovascular events in the LEADER randomized trial
so don't get too stressed assuming you'll have side effects
Obesity 23 , 565572 (2015)
Unlike FDA-approved Wegovy or Zepbound, compounded semaglutide and tirzepatide formulations have not undergone FDA review for safety, effectiveness, or manufacturing quality as finished products
Prices will rise to $199 a month for certain doses after April 15, 2026